Highlights
• People ageing between 18 and 55 and with no comorbidities are eligible to volunteer for the clinical trials of COVAXIN
• COVAXIN developed by Hyderabad-based Bharat Biotech along with the ICMR and the NIV were the first to receive an approval from the DCGI to conduct human trials
• AIIMS Delhi has started enrolling the volunteers and their screening before
Human trials f....
Tags : COVAXIN, Bharat Biotech, AIIMS Delhi, ICMR, NIV, COVID-19 vaccine,
comments (0)